Tiffany Eul Davis Inglis
Chief Medical Officer · 4 filings · Latest: Oct 12, 2026
SERA PROGNOSTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SERA | Tiffany Eul Davis Inglis | Chief Medical Officer | Oct 12, 2026 | Sale | $2.03 | 8,024 | $16.3K | 83,565 | |
SERA | Inglis Tiffany Eul Davis | — | Oct 12, 2026 | Proposed Sale | $2.03 | 8,024 | $16.3K | — | |
SERA | Tiffany Eul Davis Inglis | Chief Medical Officer | Sep 10, 2026 | Sale | $2.00 | 486 | $972 | 91,589 | |
SERA | Inglis Tiffany Eul Davis | — | Sep 10, 2026 | Proposed Sale | $2.00 | 486 | $972 | — | |
SERA | Tiffany Eul Davis Inglis | Chief Medical Officer | Jun 11, 2026 | Sale | $2.01 | 362 | $728 | 92,075 | |
SERA | Inglis Tiffany Eul Davis | — | Jun 11, 2026 | Proposed Sale | $2.01 | 362 | $726 | — |